Prospective international multicenter observational study of Novosyn® Quick for skin closures in adults and children (SKINNOQ)
Open Access
- 2 May 2019
- journal article
- research article
- Published by Springer Nature in BMC Surgery
- Vol. 19 (1) , 1-9
Abstract
This clinical trial evaluated the performance of a newly released fast-absorbable braided synthetic suture (Novosyn® Quick) in adults and paediatric patients undergoing elective skin closures. This was a prospective international multicentre observational study. Two centres enrolled 100 patients, of which 50 were adults (visceral surgery, France) and 50 were paediatric patients (paediatric surgery, Germany). Surgeons used a 5-point Likert scale to assess handling characteristics of the suture. Patients and professionals used the Patient-Observer-Scar-Assessment-Scale (POSAS) to rate scar quality. Adverse events were monitored until 3 months postoperatively. Handling characteristics of Novosyn® Quick were in median rated very good by both general surgeons and paediatric surgeons. Patient components of POSAS (six questions; ten-level Likert scale; best possible score six) scored in median (range) 8.5 (6–28) in the paediatric group versus 12 (6–38) in the adult group, P = 0.01. Patients` overall opinions of POSAS were similar in both groups [mean (SD), 1.86 (0.99) in the paediatric group versus 2.08 (1.35) in the adult group, P = 0.3536]. Observer component of POSAS (six parameters; ten-level numeric rating scale, best possible score six) scored comparably in both groups [median (range), 8 (6–29) in the paediatric group versus 10 (6–28) in the adult group, P = 0.1403]. Observers overall opinion of POSAS favoured the paediatric patients group [mean (SD), 1.48 (0.61) versus 1.92 (1.06) in the adult group, P = 0.0131]. Adverse events in relation to wound healing were not observed in both patient groups. Our findings indicate, that Novosyn® Quick is safe and reliable for skin closure in adults and paediatric patients and can be regarded as a viable alternative to Vicryl® Rapide. This trial was registered prospectively with ClinicalTrials.gov under the registration number NCT02680886 on 5 February 2016. The trial was approved by the Institutional Review Boards of both study locations (France: CCTIRS N° 16–103 and CNIL:MMS/CWR/AR163920; Germany: 398/15).Keywords
Funding Information
- B. Braun Surgical SA
This publication has 24 references indexed in Scilit:
- A randomised controlled trial of absorbable versus non-absorbable sutures for skin closure after open carpal tunnel releaseJournal of Hand Surgery (European Volume), 2011
- A prospective randomised trial of absorbable versus non-absorbable sutures for wound closure after fasciectomy for Dupuytren’s contractureJournal of Hand Surgery (European Volume), 2009
- Core outcomes for adult burn survivors: A clinical overviewBurns, 2009
- Scar assessment scales: a dermatologic overviewSkin Research and Technology, 2009
- Reliability and Validity Testing of the Patient and Observer Scar Assessment Scale in Evaluating Linear Scars after Breast Cancer SurgeryPlastic and Reconstructive Surgery, 2007
- Irradiated Polyglactin 910 (Vicryl Rapide) for Placement of Full-Thickness Skin GraftsDermatologic Surgery, 2005
- Vicryl Rapide® Versus Vicryl® Suture in Skin Closure of the Hand in Children: A Randomized Prospective StudyJournal of Hand Surgery (European Volume), 2005
- CLOSURE OF SKIN OR SCALP WITH ABSORBABLE SUTURESPlastic and Reconstructive Surgery, 2003
- How to assess postsurgical scars: A review of outcome measuresDisability and Rehabilitation, 2003
- Etude expérimentale et clinique d'un matériel de suture cutanée à résorption rapideAnnales de Chirurgie de la Main, 1988